Report for: Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women

Title	Pregnancy Incidence and Correlates during the HVTN 503 Phambili HIV Vaccine Trial Conducted among South African Women
Published in	PLOS ONE, April 2012
DOI	10.1371/journal.pone.0031387
Pubmed ID	22532824
Authors	Mary H. Latka, Katherine Fielding, Glenda E. Gray, Linda-Gail Bekker, Maphoshane Nchabeleng, Koleka Mlisana, Tanya Nielson, Surita Roux, Baningi Mkhize, Matsontso Mathebula, Nivashnee Naicker, Guy de Bruyn, James Kublin, Gavin J. Churchyard
Abstract	HIV prevention trials are increasingly being conducted in sub-Saharan Africa. Women at risk for HIV are also at risk of pregnancy. To maximize safety, women agree to avoid pregnancy during trials, yet pregnancies occur. Using data from the HVTN 503/"Phambili" vaccine trial, we report pregnancy incidence during and after the vaccination period and identify factors, measured at screening, associated with incident pregnancy.

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
South Africa	1	33%
Unknown	2	67%

Type	Count	As %
Members of the public	3	100%

Mendeley readers

The data shown below were compiled from readership statistics for 84 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Master	18	21%
Researcher	12	14%
Student > Ph. D. Student	11	13%
Student > Postgraduate	6	7%
Professor > Associate Professor	4	5%
Other	11	13%
Unknown	22	26%

Readers by discipline	Count	As %
Medicine and Dentistry	31	37%
Nursing and Health Professions	12	14%
Social Sciences	8	10%
Biochemistry, Genetics and Molecular Biology	3	4%
Psychology	2	2%
Other	4	5%
Unknown	24	29%

PLOS